Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 14;11(6):1594.
doi: 10.3390/jcm11061594.

Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review

Affiliations
Review

Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review

Céline Preux et al. J Clin Med. .

Abstract

Background: The opioid use disorder is an international public health problem. Over the past 20 years it has been the subject of numerous publications concerning patients treated for chronic pain other than cancer-related. Patients with cancer-related pain are also at risk of opioid use disorder. The primary objective of this literature review was to determine the prevalence of opioid use disorder in patients with cancer-related chronic pain. Its secondary objective was to identify the characteristics of these opioid users.

Methods: This is a literature review of studies published over the last twenty years, from 1 January 2000 to 31 December 2020 identified by searching the three main medical databases: Pubmed, Cochrane, and Embase. A meta-analysis took account of between and within-study variability with the use of random-effects models estimated by the DerSimonian and Laird method.

Results: The prevalence of opioid use disorder was 8% (1-20%) and of the risk of use disorder was 23.5% (19.5-27.8%) with I2 values of 97.8% and 88.7%, respectively.

Conclusions: Further studies are now needed on the prevalence of opioid use disorder in patients treated for cancer-related chronic pain. A screening scale adapted to this patient population is urgently needed.

Keywords: cancer; chronic pain; meta-analysis; opioid use disorder; prevalence; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the study selection.
Figure 2
Figure 2
Use disorder prevalence [18,19,20,21,22].
Figure 3
Figure 3
Risk of use disorder prevalence [19,22,23,24,25,26,27,28,29,30].
Figure 4
Figure 4
Risk of use disorder prevalence according to screening scale: (a) forest plot, (b) funnel plot [18,19,22,23,25,26,27,28,29,30].
Figure 5
Figure 5
Use disorder prevalence by sex: (a) Male; (b) Female [20,22].
Figure 6
Figure 6
Risk of use disorder prevalence by sex. (a) Male [18,20,22,23,25,26,28,29]; (b) Female [18,20,22,23,25,26,28].

References

    1. Wang X.S., Cleeland C.S., Mendoza T.R., Engstrom M.C., Liu S., Xu G., Hao X., Wang Y., Ren X.S. The Effects of Pain Severity on Health-Related Quality of Life: A Study of Chinese Cancer Patients. Cancer. 1999;86:1848–1855. doi: 10.1002/(SICI)1097-0142(19991101)86:9<1848::AID-CNCR29>3.0.CO;2-M. - DOI - PubMed
    1. Strang P. Cancer Pain—A Provoker of Emotional, Social and Existential Distress. Acta Oncol. 1998;37:641–644. doi: 10.1080/028418698429973. - DOI - PubMed
    1. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. [(accessed on 19 July 2021)]. Available online: https://www.who.int/publications-detail-redirect/9789241550390. - PubMed
    1. Mercadante S. Potential Strategies to Combat the Opioid Crisis. Expert Opin. Drug Saf. 2019;18:211–217. doi: 10.1080/14740338.2019.1579796. - DOI - PubMed
    1. Actualité—Antalgiques Opioïdes: L’ANSM Publie un État des Lieux de la Consommation en France—ANSM. [(accessed on 19 July 2021)]. Available online: https://ansm.sante.fr/actualites/antalgiques-opioides-lansm-publie-un-et....

LinkOut - more resources